MARGINAL developments
to drugs are justifying patents
allowing for artificially high drug
prices in the US, according to a
new study in the Journal of the
American Medical Association.
Brand-name drugs with patents
that grant exclusivity account for
about 72% of drug spending, even
though they are only about 10% of
all prescriptions dispensed, with
unjustifiable patent extensions
based on minor drug form or
delivery system changes, the
authors claimed.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Aug 16
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.